DK1830850T3 - Quinolin-derivater til behandling af latent tuberkulose - Google Patents

Quinolin-derivater til behandling af latent tuberkulose

Info

Publication number: DK1830850T3
Authority: DK; Denmark
Prior art keywords: treatment; quinoline derivatives; latent tuberculosis; tuberculosis; latent
Prior art date: 2004-12-24

Application number

DK05815816.3T

Other languages

English (en)

Inventor

Koenraad Jozef Lodewijk Marcel Andries

Anil Koul

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-24

Filing date

2005-12-08

Publication date

2011-06-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1830850(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-08 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2011-06-14 Application granted granted Critical

2011-06-14 Publication of DK1830850T3 publication Critical patent/DK1830850T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK05815816.3T 2004-12-24 2005-12-08 Quinolin-derivater til behandling af latent tuberkulose DK1830850T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04078529		2004-12-24
EP05105008		2005-06-08
PCT/EP2005/056594 WO2006067048A1 (en)	2004-12-24	2005-12-08	Quinoline derivatives for the treatment of latent tuberculosis

Publications (1)

Publication Number	Publication Date
DK1830850T3 true DK1830850T3 (da)	2011-06-14

Family

ID=35717702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05815816.3T DK1830850T3 (da)	2004-12-24	2005-12-08	Quinolin-derivater til behandling af latent tuberkulose

Country Status (31)

Country	Link
US (1)	US20060142279A1 (da)
EP (1)	EP1830850B1 (da)
CN (1)	CN103142595B (da)
AP (1)	AP2327A (da)
AR (1)	AR051790A1 (da)
AT (1)	ATE501721T1 (da)
AU (1)	AU2005242138B2 (da)
BR (1)	BRPI0506400B8 (da)
CA (1)	CA2529265C (da)
CR (1)	CR9267A (da)
CY (1)	CY1112247T1 (da)
DE (1)	DE602005026984D1 (da)
DK (1)	DK1830850T3 (da)
EE (1)	EE05394B1 (da)
HK (1)	HK1186125A1 (da)
HR (1)	HRP20110392T1 (da)
IL (1)	IL184123A (da)
LV (1)	LV13469B (da)
ME (1)	ME01207B (da)
MY (1)	MY145845A (da)
NI (1)	NI200700146A (da)
NO (1)	NO340376B1 (da)
NZ (1)	NZ555460A (da)
PA (1)	PA8654801A1 (da)
PL (1)	PL1830850T3 (da)
PT (1)	PT1830850E (da)
RS (1)	RS51730B (da)
SI (1)	SI1830850T1 (da)
TR (1)	TR200504892A1 (da)
TW (1)	TWI404535B (da)
WO (1)	WO2006067048A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA008937B1 (ru) *	2002-07-25	2007-10-26	Янссен Фармацевтика Н.В.	Производные хинолина и их применение в качестве микобактериальных ингибиторов
JO3270B1 (ar) *	2005-06-28	2018-09-16	Janssen Pharmaceutica Nv	مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) *	2005-06-28	2014-03-15	شركة جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
MY173664A (en) *	2005-06-28	2020-02-14	Janssen Pharmaceutica Nv	Quinoline derivatives as antibacterial agents
JO2970B1 (en)	2006-12-06	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO2683B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO3271B1 (ar)	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
JO2725B1 (en) *	2006-12-06	2013-09-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
WO2009091324A1 (en) *	2008-01-14	2009-07-23	Jyoti Chattopadhyaya	Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
RU2404971C2 (ru) *	2008-12-02	2010-11-27	ЗАО "Фарм-Синтез"	Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
CA2751892A1 (en)	2009-01-15	2010-07-22	Rutgers, The State University Of New Jersey	Benzo [c] phenanthridines as antimicrobial agents
CA2760526A1 (en)	2009-04-30	2010-11-04	Rutgers, The State University Of New Jersey	Antimicrobial agents
US8933096B2 (en)	2010-06-09	2015-01-13	Rugers, The State University of New Jersey	Antimicrobial agents
WO2011163610A2 (en) *	2010-06-25	2011-12-29	Rutgers, The State University Of New Jersey	Antimicrobial agents
WO2013106756A2 (en)	2012-01-13	2013-07-18	Rutgers, The State University Of New Jersey	Antimicrobial agents
EP2828245A1 (en)	2012-03-21	2015-01-28	Rutgers, The State University of New Jersey	Antimicrobial agents
CN104254528B (zh)	2012-04-27	2017-06-06	詹森药业有限公司	抗菌的喹啉衍生物
US9133167B2 (en)	2012-04-27	2015-09-15	Janssen Pharmaceutica Nv	Antibacterial quinoline derivatives
US9458150B2 (en)	2013-11-08	2016-10-04	Rutgers, The State University Of New Jersey	Antimicrobial agents
PL3250182T3 (pl)	2015-01-27	2023-07-31	Janssen Pharmaceutica Nv	Kompozycje dyspergowalne
JP2019507801A (ja)	2016-02-25	2019-03-22	タクシスファーマシューティカルズ，インコーポレイテッド	合成プロセス及び中間体
EP3426255B1 (en) *	2016-03-07	2022-11-30	The Global Alliance for TB Drug Development, Inc.	Antibacterial compounds and uses thereof
RU2629369C1 (ru) *	2016-10-05	2017-08-29	Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ"	Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
CN110891566B (zh)	2017-03-30	2023-12-19	塔克西斯医药股份有限公司	合成方法和合成中间体
SMT202400033T1 (it)	2017-07-14	2024-03-13	Janssen Pharmaceutica Nv	Formulazioni di bedaquilina ad azione prolungata
RU2661151C1 (ru) *	2017-12-14	2018-07-12	Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
KR20210113628A (ko)	2019-01-09	2021-09-16	얀센 파마슈티카 엔.브이.	비결핵성 마이코박테리아 질환의 치료에서의 조합물
WO2022008645A1 (en)	2020-07-09	2022-01-13	Janssen Pharmaceutica Nv	Long-acting formulations
CA3182425A1 (en)	2020-07-09	2022-01-13	Rene Holm	Long-acting formulations
EP4243800A1 (en)	2020-11-12	2023-09-20	JANSSEN Pharmaceutica NV	Combination of bedaquiline, ethambutol and a macrolide in the treatment of nontuberculous mycobacterial diseases
WO2023232838A1 (en)	2022-05-31	2023-12-07	Janssen Pharmaceutica Nv	Bedaquiline for use in the treatment of leprosy
WO2024068693A1 (en)	2022-09-28	2024-04-04	Janssen Pharmaceutica Nv	Long-acting formulations
TW202423427A (zh)	2022-09-28	2024-06-16	比利時商健生藥品公司	長效配方
WO2025068448A1 (en)	2023-09-28	2025-04-03	Janssen Pharmaceutica Nv	Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR038536A1 (es) *	2002-02-25	2005-01-19	Upjohn Co	N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
EA008937B1 (ru) *	2002-07-25	2007-10-26	Янссен Фармацевтика Н.В.	Производные хинолина и их применение в качестве микобактериальных ингибиторов

2005
- 2005-12-05 EE EEP200500033A patent/EE05394B1/xx unknown
- 2005-12-06 CA CA2529265A patent/CA2529265C/en active Active
- 2005-12-07 PA PA20058654801A patent/PA8654801A1/es unknown
- 2005-12-07 MY MYPI20055732A patent/MY145845A/en unknown
- 2005-12-07 AU AU2005242138A patent/AU2005242138B2/en active Active
- 2005-12-08 AP AP2007004054A patent/AP2327A/xx active
- 2005-12-08 EP EP05815816A patent/EP1830850B1/en active Active
- 2005-12-08 WO PCT/EP2005/056594 patent/WO2006067048A1/en active Application Filing
- 2005-12-08 SI SI200531294T patent/SI1830850T1/sl unknown
- 2005-12-08 NZ NZ555460A patent/NZ555460A/en unknown
- 2005-12-08 AT AT05815816T patent/ATE501721T1/de active
- 2005-12-08 RS RS20110221A patent/RS51730B/en unknown
- 2005-12-08 US US11/296,992 patent/US20060142279A1/en not_active Abandoned
- 2005-12-08 PT PT05815816T patent/PT1830850E/pt unknown
- 2005-12-08 CN CN201210507318.XA patent/CN103142595B/zh active Active
- 2005-12-08 ME MEP-2011-92A patent/ME01207B/me unknown
- 2005-12-08 DE DE602005026984T patent/DE602005026984D1/de active Active
- 2005-12-08 TW TW094143290A patent/TWI404535B/zh active
- 2005-12-08 DK DK05815816.3T patent/DK1830850T3/da active
- 2005-12-08 TR TR2005/04892A patent/TR200504892A1/xx unknown
- 2005-12-08 BR BRPI0506400A patent/BRPI0506400B8/pt active IP Right Grant
- 2005-12-08 PL PL05815816T patent/PL1830850T3/pl unknown
- 2005-12-09 AR ARP050105140A patent/AR051790A1/es unknown
- 2005-12-09 LV LVP-05-161A patent/LV13469B/lv unknown
2007
- 2007-06-05 NI NI200700146A patent/NI200700146A/es unknown
- 2007-06-21 IL IL184123A patent/IL184123A/en active IP Right Grant
- 2007-07-20 CR CR9267A patent/CR9267A/es not_active Application Discontinuation
- 2007-07-23 NO NO20073823A patent/NO340376B1/no unknown
2011
- 2011-05-24 HR HR20110392T patent/HRP20110392T1/hr unknown
- 2011-06-15 CY CY20111100563T patent/CY1112247T1/el unknown
2013
- 2013-12-09 HK HK13113666.1A patent/HK1186125A1/xx unknown

Also Published As

Publication number	Publication date
CR9267A (es)	2008-09-09
US20060142279A1 (en)	2006-06-29
PT1830850E (pt)	2011-05-31
EP1830850B1 (en)	2011-03-16
EP1830850A1 (en)	2007-09-12
WO2006067048A1 (en)	2006-06-29
EE200500033A (et)	2006-08-15
CN103142595B (zh)	2015-05-06
DE602005026984D1 (de)	2011-04-28
AU2005242138A1 (en)	2006-07-13
AP2327A (en)	2011-11-25
IL184123A (en)	2011-10-31
TR200504892A1 (tr)	2010-04-21
HK1186125A1 (en)	2014-03-07
BRPI0506400B1 (pt)	2021-04-06
RS51730B (en)	2011-10-31
CN103142595A (zh)	2013-06-12
NO20073823L (no)	2007-07-23
CY1112247T1 (el)	2015-12-09
AP2007004054A0 (en)	2007-06-30
TW200637551A (en)	2006-11-01
BRPI0506400B8 (pt)	2021-05-25
MY145845A (en)	2012-04-30
SI1830850T1 (sl)	2011-07-29
NI200700146A (es)	2019-05-10
AR051790A1 (es)	2007-02-07
TWI404535B (zh)	2013-08-11
HRP20110392T1 (hr)	2011-06-30
NZ555460A (en)	2008-11-28
ME01207B (me)	2013-03-20
CA2529265A1 (en)	2006-06-24
PL1830850T3 (pl)	2011-07-29
CA2529265C (en)	2014-02-11
NO340376B1 (no)	2017-04-10
ATE501721T1 (de)	2011-04-15
PA8654801A1 (es)	2006-08-03
LV13469B (en)	2007-01-20
BRPI0506400A8 (pt)	2017-09-12
BRPI0506400A (pt)	2006-08-29
EE05394B1 (et)	2011-04-15
IL184123A0 (en)	2008-12-29
AU2005242138B2 (en)	2011-05-26

Publication	Publication Date	Title
DK1830850T3 (da)	2011-06-14	Quinolin-derivater til behandling af latent tuberkulose
CY2022001I1 (el)	2022-03-24	Παραγωγα του uk-2a
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DK1737461T3 (da)	2013-03-18	Carbolin-derivater til inhibering af angiogenese
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1805312T3 (da)	2009-10-19	Fremgangsmåder og midler til fremstilling af hyaluronan
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1962830T3 (da)	2013-06-24	Azaindolhæmmere af aurorakinaser.
DK1928438T3 (da)	2013-04-22	Anvendelse af ibudilast til behandling af stofafhængighed
DK3456707T3 (da)	2020-07-20	4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2402005T3 (da)	2021-03-15	Formuleringer med langvarig frigivelse af nalbuphin
DK2094676T3 (da)	2013-06-10	Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK1701941T3 (da)	2012-08-13	Forbindelser til behandling af sygdomme med celleproliferation
DK1791820T3 (da)	2010-04-06	Enantioselektiv fremstilling af quinolinderivater
DK1708991T3 (da)	2008-01-14	Sulfonamid derivater til behandling af sygdomme
DK1968574T3 (da)	2011-11-21	Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af obesitet
DK1817282T3 (da)	2011-10-10	Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK1844039T3 (da)	2009-11-09	5-substituerede quinolin- og isoquinolin-derivater, fremgangsmåde til fremstilling af disse og deres anvendelse som betændelseshæmmende midler
DK1701944T3 (da)	2009-11-09	2-(amino-substituerede)-4-aryl-pyramidiner og relaterede forbindelser til behandling af inflammationssygdomme
NO20070299L (no)	2007-03-26	Novel heterocyclic compounds
DK1763520T3 (da)	2009-02-09	Anvendelse af trisubstituerede benzopyranoner
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK1814555T3 (da)	2009-12-07	S-mirtazapin til behandling af hedeture
ZA200705160B (en)	2008-09-25	Quinoline derivatives for the treatment of latent tuberculosis